238 related articles for article (PubMed ID: 37398987)
1. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government.
van der Pol KH; Aljofan M; Blin O; Cornel JH; Rongen GA; Woestelandt AG; Spedding M
Appl Health Econ Health Policy; 2023 Nov; 21(6):831-840. PubMed ID: 37398987
[TBL] [Abstract][Full Text] [Related]
2. Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance.
Bloom BE
Assay Drug Dev Technol; 2015 Dec; 13(10):606-11. PubMed ID: 26284286
[TBL] [Abstract][Full Text] [Related]
3. Challenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease Treatments.
DiCarlo AL; Cassatt DR; Dowling WE; Esker JL; Hewitt JA; Selivanova O; Williams MS; Price PW
Radiat Res; 2018 Dec; 190(6):659-676. PubMed ID: 30160600
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers.
Begley CG; Ashton M; Baell J; Bettess M; Brown MP; Carter B; Charman WN; Davis C; Fisher S; Frazer I; Gautam A; Jennings MP; Kearney P; Keeffe E; Kelly D; Lopez AF; McGuckin M; Parker MW; Rayner C; Roberts B; Rush JS; Sullivan M
Sci Transl Med; 2021 Sep; 13(612):eabd5524. PubMed ID: 34550729
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
6. Drug repurposing in rare diseases: Myths and reality.
Fetro C; Scherman D
Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
[TBL] [Abstract][Full Text] [Related]
7. Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.
Rogosnitzky M; Berkowitz E; Jadad AR
JMIR Public Health Surveill; 2020 May; 6(2):e19199. PubMed ID: 32374264
[TBL] [Abstract][Full Text] [Related]
8. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
Mittal N; Mittal R
Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
[TBL] [Abstract][Full Text] [Related]
9. The trials and tribulations of repurposing metformin and other generic drugs for tuberculosis.
Bloom BE
Pharm Pat Anal; 2016; 5(2):101-5. PubMed ID: 26889918
[TBL] [Abstract][Full Text] [Related]
10. Drug repurposing: From the discovery of a useful pharmacological effect to making the treatment available to the patient.
Deplanque D; Fetro C; Ferry A; Lechat P; Beghyn T; Bernard C; Bernasconi A; Bienayme H; Cougoule C; Del Bano J; Demiot C; Lebrun-Vignes B
Therapie; 2023; 78(1):10-18. PubMed ID: 36528417
[TBL] [Abstract][Full Text] [Related]
11. Challenges and Benefits of Repurposing Licensed/Approved/Cleared Products for a Radiation Indication.
Price PW; DiCarlo AL
Radiat Res; 2018 Dec; 190(6):654-658. PubMed ID: 30281977
[TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access.
Greenblatt W; Gupta C; Kao J
Health Aff (Millwood); 2023 Mar; 42(3):424-432. PubMed ID: 36877896
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on Drug Repurposing.
Schcolnik-Cabrera A; Juárez-López D; Duenas-Gonzalez A
Curr Med Chem; 2021; 28(11):2085-2099. PubMed ID: 32867630
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
Ng YL; Salim CK; Chu JJH
Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing: a systematic review on root causes, barriers and facilitators.
Krishnamurthy N; Grimshaw AA; Axson SA; Choe SH; Miller JE
BMC Health Serv Res; 2022 Jul; 22(1):970. PubMed ID: 35906687
[TBL] [Abstract][Full Text] [Related]
16. On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients.
Verbaanderd C; Rooman I; Meheus L; Huys I
Front Pharmacol; 2019; 10():1664. PubMed ID: 32076405
[TBL] [Abstract][Full Text] [Related]
17. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
18. How health technology assessment can help to address challenges in drug repurposing: a conceptual framework.
Abu-Zahra T; Grimm SE; Scholte M; Raymakers AJN; Kesselheim AS; Joore M
Drug Discov Today; 2024 Jun; 29(6):104008. PubMed ID: 38692506
[TBL] [Abstract][Full Text] [Related]
19. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.
Polamreddy P; Gattu N
Drug Discov Today; 2019 Mar; 24(3):789-795. PubMed ID: 30513339
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
